Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination

被引:0
|
作者
SK Sharma
J Pokorski
MG Finn
J Jacqueline
E Rakasz
D Burton
R Wyatt
机构
[1] International AIDS Vaccine Initiative,Wisconsin National Primate Research Center
[2] The Scripps Research Institute,undefined
[3] Univ. of Wisconsin-Madison,undefined
关键词
Protective Efficacy; Envelope Glycoprotein; Bacteriophage Particle; Passive Immunization; Protective Capacity;
D O I
10.1186/1742-4690-9-S2-P37
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination
    Sharma, S. K.
    Pokorski, J.
    Finn, M. G.
    Jacqueline, J.
    Rakasz, E.
    Burton, D.
    Wyatt, R.
    RETROVIROLOGY, 2012, 9
  • [2] Characterization of HR Region of gp41 of HIV
    Qadir, M. Imran
    Malik, Salman Akbar
    Tehzeeb-Ul-Nisa
    Tabassum, Nadia
    Ali, Sajid
    Nisar, Lubna
    INTERNATIONAL JOURNAL OF AGRICULTURE AND BIOLOGY, 2010, 12 (03) : 456 - 458
  • [3] Immobilization of HIV GP41 antibodies on glass substrates for HIV biosensing
    Manoto, Sello
    El-Hussein, Ahmed
    Malabi, Rudzani
    Thobakgale, Lebogang
    Ombinda-Lemboumba, Saturnin
    Attia, Yasser
    Kasem, Mohammed
    Mthunzi-Kufa, Patience
    FRONTIERS IN BIOLOGICAL DETECTION: FROM NANOSENSORS TO SYSTEMS XII, 2020, 11258
  • [4] Neutralizing Antibodies Targeting HIV-1 gp41
    Caillat, Christophe
    Guilligay, Delphine
    Sulbaran, Guidenn
    Weissenhorn, Winfried
    VIRUSES-BASEL, 2020, 12 (11):
  • [5] Vaccination induces broadly neutralizing antibody precursors to HIV gp41
    Schiffner, Torben
    Phung, Ivy
    Ray, Rashmi
    Irimia, Adriana
    Tian, Ming
    Swanson, Olivia
    Lee, Jeong Hyun
    Lee, Chang-Chun D.
    Marina-Zarate, Ester
    Cho, So Yeon
    Huang, Jiachen
    Ozorowski, Gabriel
    Skog, Patrick D.
    Serra, Andreia M.
    Rantalainen, Kimmo
    Allen, Joel D.
    Baboo, Sabyasachi
    Rodriguez, Oscar L.
    Himansu, Sunny
    Zhou, Jianfu
    Hurtado, Jonathan
    Flynn, Claudia T.
    Mckenney, Katherine
    Havenar-Daughton, Colin
    Saha, Swati
    Shields, Kaitlyn
    Schulze, Steven
    Smith, Melissa L.
    Liang, Chi-Hui
    Toy, Laura
    Pecetta, Simone
    Lin, Ying-Cing
    Willis, Jordan R.
    Sesterhenn, Fabian
    Kulp, Daniel W.
    Hu, Xiaozhen
    Cottrell, Christopher A.
    Zhou, Xiaoya
    Ruiz, Jennifer
    Wang, Xuesong
    Nair, Usha
    Kirsch, Kathrin H.
    Cheng, Hwei-Ling
    Davis, Jillian
    Kalyuzhniy, Oleksandr
    Liguori, Alessia
    Diedrich, Jolene K.
    Ngo, Julia T.
    Lewis, Vanessa
    Phelps, Nicole
    NATURE IMMUNOLOGY, 2024, 25 (06) : 1073 - 1082
  • [6] Mechanism of HIV-1 Neutralization by Antibodies Targeting a Membrane-Proximal Region of gp41
    Chen, Jia
    Frey, Gary
    Peng, Hanqin
    Rits-Volloch, Sophia
    Garrity, Jetta
    Seaman, Michael S.
    Chen, Bing
    JOURNAL OF VIROLOGY, 2014, 88 (02) : 1249 - 1258
  • [7] The membrane-perturbing actions of HIV glycoprotein 41 (gp41) domains are inhibited by the C-leucine zipper region of gp41
    Mobley, PW
    Barry, JA
    Waring, AJ
    Gordon, LM
    PROTEIN SCIENCE, 2004, 13 : 133 - 133
  • [8] Induction of antibodies with specificity for gp41 neutralizing epitopes by membrane anchored gp41 immunogens
    Alam, S.
    Dennison, S. M.
    Jaeger, F.
    Anasti, K.
    Sutherland, L.
    Bowman, C.
    Parks, R.
    Santra, S.
    Shen, S.
    Tomaras, G.
    Montefiori, D.
    Letvin, N.
    Haynes, B. F.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A64 - A64
  • [9] Virus Like Particle Based Strategy to Elicit Antibodies to an HIV-Protective Epitope Within the Alpha-Helic Region of gp41
    Asti, V.
    Pastori, C.
    Diomede, L.
    Longhi, R.
    Rohn, T. A.
    Jegerlehner, A.
    Lopalco, L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 : 73 - 73
  • [10] Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop
    Caffrey, M
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2001, 1536 (2-3): : 116 - 122